Blue Gene Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-07-2024
- Paid Up Capital ₹ 0.10 M
as on 17-07-2024
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.86 M
as on 17-07-2024
- Satisfied Charges ₹ 31.00 Cr
as on 17-07-2024
- Revenue -16.83%
(FY 2023)
- Profit -31.65%
(FY 2023)
- Ebitda -7.45%
(FY 2023)
- Net Worth 7.09%
(FY 2023)
- Total Assets -3.59%
(FY 2023)
About Blue Gene
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.86 M. The company has closed loans amounting to ₹31.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kantipudi Suma and Kovelamudi Prasad serve as directors at the Company.
- CIN/LLPIN
U85100TG2010PTC067176
- Company No.
067176
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Feb 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Blue Gene?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kovelamudi Prasad  | Director | 08-Jan-2018 | Current |
| Kantipudi Suma | Director | 23-Feb-2010 | Current |
Financial Performance of Blue Gene.
Blue Gene Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.83% decrease. The company also saw a substantial fall in profitability, with a 31.65% decrease in profit. The company's net worth moved up by a moderate rise of 7.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Blue Gene?
In 2023, Blue Gene had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Prasad Hospitals India Private LimitedActive 14 years 9 monthsKantipudi Suma and Kovelamudi Prasad are mutual person
- Prasad Research FoundationActive 7 years 6 months
Kantipudi Suma and Kovelamudi Prasad are mutual person
Prasad Property Management Private LimitedActive 2 years 8 monthsKantipudi Suma and Kovelamudi Prasad are mutual person
- Hsrl Enterprises Private LimitedActive 5 years 5 months
Kantipudi Suma and Kovelamudi Prasad are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 29 Apr 2023 | ₹5.83 M | Open |
Axis Bank Limited Creation Date: 16 Dec 2019 | ₹2.03 M | Open |
Others Creation Date: 21 Oct 2022 | ₹31.00 Cr | Satisfied |
How Many Employees Work at Blue Gene?
Unlock and access historical data on people associated with Blue Gene, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Blue Gene, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blue Gene's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
